2,100
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

IgM cleavage by Streptococcus suis reduces IgM bound to the bacterial surface and is a novel complement evasion mechanism

, , , , , , ORCID Icon, , , , , & ORCID Icon show all
Pages 1314-1337 | Received 13 Mar 2018, Accepted 22 Jun 2018, Published online: 28 Aug 2018

References

  • Staats JJ, Feder I, Okwumabua O, et al. Streptococcus suis: past and present. Vet Res Commun. 1997;21:381–407.
  • Baele M, Chiers K, Devriese LA, et al. The Gram-positive tonsillar and nasal flora of piglets before and after weaning. J Appl Microbiol. 2001;91:997–1003.
  • Segura M, Calzas C, Grenier D, et al. Initial steps of the pathogenesis of the infection caused by Streptococcus suis: fighting against nonspecific defenses. FEBS Lett. 2016;590:3772–3799.
  • Goyette-Desjardins G, Auger J-P, Xu J, et al. Streptococcus suis, an important pig pathogen and emerging zoonotic agent—an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect. 2014;3:e45.
  • Okura M, Osaki M, Nomoto R, et al. Current taxonomical situation of Streptococcus suis. Pathogens. 2016;5:45.
  • Fittipaldi N, Segura M, Grenier D, et al. Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Futur Microbiol. 2012;7:259–279.
  • Segura M, Fittipaldi N, Calzas C, et al. Critical Streptococcus suis virulence factors: are they all really critical? Trends Microbiol. 2017;25:585–599.
  • Lecours M-P, Gottschalk M, Houde M, et al. Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. J Infect Dis. 2011;204:919–929.
  • Roy D, Grenier D, Segura M, et al. Recruitment of factor H to the Streptococcus suis Cell surface is multifactorial. Pathogens. 2016;5:47.
  • Seele J, Beineke A, Hillermann LM, et al. The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is involved in complement evasion. Vet Res. 2015;46:1–14.
  • Seele J, Singpiel A, Spoerry C, et al. Identification of a novel host-specific IgM Protease in Streptococcus suis. J Bacteriol. 2013;195:930–940.
  • Rungelrath V, Wohlsein JC, Siebert U, et al. Identification of a novel host-specific IgG protease in Streptococcus phocae subsp. phocae. Vet Microbiol. 2017;201:42–48.
  • Ochsenbein AF, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today. 2000;5699:624–630.
  • Tizard IR. Veterinary immunology. 9th ed. St. Louis (MO): Elsevier Health Sciences; 2013.
  • Klimovich VB. IgM and its receptors: structural and functional aspects. Biochemistry (Mosc). 2011;76:534–549.
  • Bennett KM, Rooijakkers SHM, Gorham RD. Let’s tie the knot: marriage of complement and adaptive immunity in pathogen evasion, for better or worse. Front Microbiol. 2017;8:1–17.
  • Heyman B, Wigzell H. Specific IgM enhances and IgG inhibits the induction of immunological memory in mice. Scand J Immunol. 1985;21:255–266.
  • Sun J, Butler JE. Sequence analysis of pig switch mu, C mu, and C mu m. Immunogenetics. 1997;46:452–460.
  • Thorgersen EB, Pharo A, Haverson K, et al. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood. Infect Immun. 2009;77:725–732.
  • Seele J, Hillermann LM, Beineke A, et al. The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2. Vaccine. 2015;33:2207–2212.
  • Lynskey NN, Reglinski M, Calay D, et al. Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase. PLoS Pathog. 2017;13:1–29.
  • Buffalo CZ, Bahn-Suh AJ, Hirakis SP, et al. Conserved patterns hidden within group A Streptococcus M protein hypervariability recognize human C4b-binding protein. Nat Microbiol. 2016;1:16155.
  • Frick I-M, Rasmussen M, Schmidtchen A, et al. SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem. 2003;278(19):16561–16566.
  • Kraiczy P, Hellwage J, Skerka C, et al. Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family. Eur J Immunol. 2003;33:697–707.
  • Lathem WW, Bergsbaken T, Welch RA. Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7. J Exp Med. 2004;199:1077–1087.
  • Li Q, Ma C, Fu Y, et al. H specifically capture novel Factor H-binding proteins of Streptococcus suis and contribute to the virulence of the bacteria. Microbiol Res. 2017;196:17–25.
  • Seitz M, Beineke A, Singpiel A, et al. Role of Capsule and Suilysin in Mucosal Infection of Complement-Deficient Mice with Streptococcus suis. Infect Immun. 2014;82:2460–2471.
  • Nordenfelt P, Waldemarson S, Linder A, et al. Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med. 2012;209:2367–2381.
  • Mäkelä O, Rouslahti E, Seppälä IJT. Affinity of IgM and IgG antibodies. Immunochemistry. 1970;7:917–932.
  • Söderberg JJ, von Pawel-Rammingen U. The streptococcal protease IdeS modulates bacterial IgGFc binding and generates 1/2Fc fragments with the ability to prime polymorphonuclear leucocytes. Mol Immunol. 2008;45:3347–3353.
  • Brown JS, Hussell T, Gilliland SM, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA. 2002;99:16969–16974.
  • Kerr AR, Paterson GK, Riboldi-Tunnicliffe A, et al. Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3. Infect Immun. 2005;73:4245–4252.
  • Paterson GK, Mitchell TJ. Innate immunity and the pneumococcus. Microbiology. 2006;152:285–293.
  • Bogaert D, Thompson CM, Trzcinski K, et al. The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model. Vaccine. 2010;28:681–685.
  • Okumura CYM, Anderson EL, Döhrmann S, et al. IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus. MBio. 2013;4:e00499–13 – e00499–13.
  • Xiao G, Wu Z, Zhang S, et al. Mac Protein is not an Essential Virulence Factor for the Virulent Reference Strain Streptococcus suis P1/7. Curr Microbiol. 2017;74(1):90–96.
  • Plebani A, Mira E, Mevio E, et al. IgM and IgD concentrations in the serum and secretions of children with selective IgA deficiency. Clin Exp Immunol. 1983;53:689–696.
  • Michaelsen TE, Emilsen S, Sandin RH, et al. Human secretory IgM antibodies activate human complement and offer protection at mucosal surface. Scand J Immunol. 2017;85:43–50.
  • Butler JE, Sun J, Navarro P. The swine Ig heavy chain locus has a single JH and no identifiable IgD. Int Immunol. 1996;8:1897–1904.
  • Shima H, Takatsu H, Fukuda S, et al. Identification of TOSO/FAIM3 as an Fc receptor for IgM. Int Immunol. 2010;22:149–156.
  • Smith HE, Damman M, van der Velde J, et al. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect Immun. 1999;67:1750–1756.
  • de Buhr N, Reuner F, Neumann A, et al. Neutrophil extracellular trap formation in the Streptococcus suis-infected cerebrospinal fluid compartment. Cell Microbiol. 2017;19:1–16.
  • Green MR, Sambrook J. Molecular cloning: a laboratory manual. 4th ed. Long Island (NY): Cold Spring Harbor Lab. Press; 2012.
  • Beineke A, Bennecke K, Neis C, et al. Comparative evaluation of virulence and pathology of Streptococcus suis serotypes 2 and 9 in experimentally infected growers. Vet Microbiol. 2008;128:423–430.
  • Takamatsu D, Osaki M, Sekizaki T. Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid. 2001;46:140–148.
  • Baums CG, Kaim U, Fulde M, et al. Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infect Immun. 2006;74:6154–6162.
  • Hammerschmidt S, Wolff S, Hocke A, et al. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun. 2005;73:4653–4667.
  • Baums CG, Kock C, Beineke A, et al. Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9. Clin Vaccine Immunol. 2009;16:200–208.
  • Messias-Reason IJ, Hayashi SY, Nisihara RM, et al. Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis. Clin Exp Immunol. 2002;127:310–315.
  • Mollnes TE, Lea T, Frøland SS, et al. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol. 1985;22:197–202.
  • Silva LMG, Baums CG, Rehm T, et al. Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Vet Microbiol. 2006;115:117–127.